The Hepatorenal Syndrome

  • A. F. Hammerle
  • P. Krafft
  • C. Tatschl
Conference paper


The term “Hepatorenal Syndrome” (HRS) has been frequently used to refer to several episodes of simultaneous impairment of both renal and hepatic function.


Portal Hypertension Atrial Natriuretic Peptide Transjugular Intrahepatic Portosystemic Shunt Orthotopic Liver Transplantation Hepatorenal Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Arroyo V, Gines P, Gerbes AL et al (1996) Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 23 (1):164–176PubMedCrossRefGoogle Scholar
  2. 2.
    Hecker R, Sherlock S (1956) Lancet ii:1121CrossRefGoogle Scholar
  3. 3.
    Papper S, Belsky J, Bleifer KH (1959) Ann Int Med 51:759PubMedCrossRefGoogle Scholar
  4. 4.
    Epstein M, Ber DP, Hollenberg NK et al (1970) AM J Med 49:175PubMedCrossRefGoogle Scholar
  5. 5.
    Koppel MH, Coburn JW, Mims MM et al (1969) N Engl J Med 280:1367PubMedCrossRefGoogle Scholar
  6. 6.
    Iwatsuki S, Popovtzer M, Corman JL et al (1973) N Engl J Med 289:1155PubMedCrossRefGoogle Scholar
  7. 7.
    Epstein M, Berk DP, Hollenberg NK et al (1970) Renal failure in patients with cirrhosis. The role of active vasoconstriction. Am J Med 49:175–185PubMedCrossRefGoogle Scholar
  8. 8.
    Maxine A, Papadakis, Allen I et al (1987) Unpredictability of clinical evaluation of renal function in Cirrhosis. Prospective Study. Am J Med. Volume 82:945–952CrossRefGoogle Scholar
  9. 9.
    Papper S, Belsky JL, Bleifer KH (1959) Renal failure in Laennec’s cirrhosis of the liver. Description of clinical and laboratory features. Ann Intern Med 51:759–773PubMedCrossRefGoogle Scholar
  10. 10.
    Kowalski HJ, Abelman WH (1953) The cardiac output at rest in Laennec’s cirrhosis. J Clin Invest 32:1025–1033PubMedCrossRefGoogle Scholar
  11. 11.
    Vorobioff J, Bredfeldt JE, Groszmann RJ (1983) Hyperdynamic circulation in portal hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiology 244:G52-G57Google Scholar
  12. 12.
    Colombato LA, Albillos A, Groszmann J (1991) Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portalhypertensive rats. Hepatology 15:323–328CrossRefGoogle Scholar
  13. 13.
    Granger DN, Kevietys PR, Korthuis RJ et al (1989) Microcirculation of the intestinal mucosa. Wood JD (ed) Handbook of physiology. Baltimore: Waverly Press 1505–1474Google Scholar
  14. 14.
    Gallavan RH, Parks DA, Jacoboson ED (1989) Pathophysiology of gastrointestinal circulation. Wood JD (ed) Handbook of physiology. Baltimore: Waverly Press 1713–1732Google Scholar
  15. 15.
    Sikuler E, Kravetz D, Groszman RJ (1985) Evolution of portal-hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol 248:G618-G625PubMedGoogle Scholar
  16. 16.
    Schrier RW, Arroyo V, Bernardi M et al (1988) Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8:1151–1157PubMedCrossRefGoogle Scholar
  17. 17.
    Bichet DG, Van Putten VJ, Schrier RW (1982) Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med 307:1552–1557PubMedCrossRefGoogle Scholar
  18. 18.
    Henriksen JH, Ring-Larsen H, Kanstrup IL et al (1984) Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis. Gut 25:1034–1043PubMedCrossRefGoogle Scholar
  19. 19.
    DiBona GF (1984) Renal neural activity in hepatorenal syndrome. Kidney Int 25:841–853PubMedCrossRefGoogle Scholar
  20. 20.
    Rodriguez-Martinez M, Sawin LL, DiBona GF (1995) Arterial and cardiopulmonary baroreflex control of renal nerve activity in cirrhosis. Am J Physiol. 1995 Jan; 268(1 Pt 2): R117–129Google Scholar
  21. 21.
    Soliz-Herruzo JA, Duran A, Favela V et al (1987) Hepatology 5:167CrossRefGoogle Scholar
  22. 22.
    Soliz-Herruzo JA, Duran A, Favela V et al (1987) Effect of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome. Hepatology 7:167–173Google Scholar
  23. 23.
    Esler M, Dudley F, Jennings G et al (1992) Increased sympathetic nervous activitiy and the effects of its inhibition with clonidine in alcoholic cirrhosis. Ann Intern Med 116:446–455PubMedCrossRefGoogle Scholar
  24. 24.
    Epstein M, Levinson R, Sancho J et al (1977) Characterization of the renin-aldosterone system in decompensated cirrhosis. Circ Res 41:818–829PubMedCrossRefGoogle Scholar
  25. 25.
    Barnardo D, Summerskill WHJ, Strong CG et al (1970) Renal function, renal activity and endogenous vasoactive substances in cirrhosis. Am J Dig Dis 15:419–425PubMedCrossRefGoogle Scholar
  26. 26.
    Schroeder ET, Eich RH, Smulyan H et al (1970) Plasma renin level in hepatic cirrhosis: Relation to functional renal failure. Am J Med 49:189–191CrossRefGoogle Scholar
  27. 27.
    Bernardi M, Fornale L, Di Marco C et al (1995) Hyperdynamic circulation of advanced cirrhosis: a re-appraisal based on posture-induced changes in hemodynamics. J Hepatol 22 (3):309–318PubMedCrossRefGoogle Scholar
  28. 28.
    Yaniasigawa M, Kurihara H, Kimura S et al (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415CrossRefGoogle Scholar
  29. 29.
    Vanhoutte PM (1988) The endothelium: modulator of vascular smooth muscle. N Engl J Med 319:512–513PubMedCrossRefGoogle Scholar
  30. 30.
    Rees DD, Palmer RMJ, Moncada S (1989) Role of endothelium derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci 86:3375–3378PubMedCrossRefGoogle Scholar
  31. 31.
    Palmer RMJ, Ferrige AG, Moncada S (1988) Vascular endothelial cells synthesize nitiric oxide from L-arginine. Nature 333:664–666PubMedCrossRefGoogle Scholar
  32. 32.
    Vallance P, Moncada S (1991) Hyperdynamic circulation in cirrhosis: a role for nitric oxid. Lancet 337:776–778PubMedCrossRefGoogle Scholar
  33. 33.
    Lumsden AB, Henderson JM, Kutner MH (1988) Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 8:232–236PubMedCrossRefGoogle Scholar
  34. 34.
    Tilg H, Wilmer A, Vogel W et al (1992) Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264–274PubMedGoogle Scholar
  35. 35.
    McCall TB, Boughton-Smith NK, Palmer RMJ et al (1989) Synthesis of nitric oxide from L-arginine by neutrophils: release and interaction with superoxide anion. Biochem J 261: 293–296PubMedGoogle Scholar
  36. 36.
    Conrado M, Fernandez R, Prieto J et al (1995) Plasma levels of substance P in liver cirrhosis: Relationship to the activation of vasopressor systems and urinary sodium excretion. Hepatology 21:35–40Google Scholar
  37. 37.
    Burke GW, Cirocco R, Roth D et al (1993) Acitvated cytokine pattern in hepatorenal syndrome: Fall in levels after successful orthotopic liver transplantation. Transplantation Proceedings, Vol 25, No 2:1876–1877PubMedGoogle Scholar
  38. 38.
    Laffi G, Foschi M, Masini E et al (1995) Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. Hepatology 22:1666–1673PubMedGoogle Scholar
  39. 39.
    Mathie RT, Ralevic V, Moore KP et al (1996) Mesenteric vasodilator responses in cirrhotic rats: a role for nitric oxide. Hepatology 23(1):130–136PubMedCrossRefGoogle Scholar
  40. 40.
    Yaniasigawa M, Kurihara H, Kimura S et al (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415CrossRefGoogle Scholar
  41. 41.
    Rabelink AJ, Kaasjager HAH, Boer P et al (1994) Effects of endothelin-1 on renal function in humans. Implications for physiology and pathophysiology. Kidney Int 46:376–381PubMedCrossRefGoogle Scholar
  42. 42.
    Loutzenhiser R, Epstein M, Hayashi K et al (1990) Direct visualization of the effects of endothelin on the renal microvasculature. Am J Pysiol 258:F61-F68Google Scholar
  43. 43.
    Takenaka T, Forster H, Epstein M (1993) Protein Kinase C and calcium channel activation as determinants of renal vasoconstriction by angiotensin II and endothelin. Circ Res 73:743–750PubMedCrossRefGoogle Scholar
  44. 44.
    Maddedu P, Troffa C, Glorioso N et al (1989) Effect of endothelin on regional hemodynamics and renal function in awake normotensive rats. J Cardiovasc Pharmacol 14:818–825CrossRefGoogle Scholar
  45. 45.
    Salo J, Francitorra A, Folio A et al (1995) Increased plasma endothelin in cirrhosis. J Hepatology 22(4):389–398CrossRefGoogle Scholar
  46. 46.
    Joost A, Bijlsma, Rabelink AJ et al (1995) L-arginine does not prevent the renal effects of endothelin in humans. J Am Soc Nephrol 5:1508–1516Google Scholar
  47. 47.
    Moore K, Wendon J, Frazer M et al (1992) Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med 327:1774–1778PubMedCrossRefGoogle Scholar
  48. 48.
    Nozue T, Kobayashi A, Uemasu F et al (1995) Plasma endothelin-1 levels of children with cirrhosis. J Pediatr Gastroenterol Nutr. Vol 21(2):220–223PubMedCrossRefGoogle Scholar
  49. 49.
    Zipser RD, Radvan GH, Kronberg IJ et al (1983) Gastroenterology 84:697PubMedGoogle Scholar
  50. 50.
    Ros J, Claria J, Jiminez W et al (1995) Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis. Hepatology 22(3):915–920PubMedGoogle Scholar
  51. 51.
    Perez-Ayuso RM, Arroyo V, Camps J et al (1984) Renal kallikrein excretion in cirrhotics with ascites: Relationship to renal hemodynamic. Hepatology 4:247–252PubMedCrossRefGoogle Scholar
  52. 52.
    Laffi G, LaVilla G, Gentilini P (1994) Pathogenesis and Management of the Hepatorenal Syndrome. Seminars in Liver Disease. Vol 14(1):71–81PubMedCrossRefGoogle Scholar
  53. 53.
    Epstein M (1995) Hepatorenal syndrome - Current concepts of pathophysiology and therapy. In: Bellomo R, Ronco C (eds) Update in intensive care and emergency medicine 20, Springer, pp 215–245Google Scholar
  54. 54.
    Mandal AK, Lansing M, Fahmy A (1982) Acute tubular necrosis in hepatorenal syndrome: An electron microscopic study. Am J Kidney Dis 2:368–374Google Scholar
  55. 55.
    Wamatz K, Schweigart U, Endres N et al (1994) Ornipressin in der Therapie des hepatoralen Syndroms. Intensivmed 32:287–293Google Scholar
  56. 56.
    Lenz K, Hortnagl H, Druml W et al (1989) Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis. Gut 30:90–96PubMedCrossRefGoogle Scholar
  57. 57.
    Giostra E, Ruedin P et al (1995) Sustained effects on ornipressin in hepatorenal syndrome. J Hepatology 22(1):120–121CrossRefGoogle Scholar
  58. 58.
    Durkin R, Winter SM (1995) Reversal of hepatorenal syndrome with the combination of norepinephrine and dopamine. Critical Care Medicine. Vol 23(l):202–204PubMedCrossRefGoogle Scholar
  59. 59.
    Rössle M, Richter GM, Nöldge G et al (1989) New non-operative treatment tor variceal hemorrhage. Lancet 2:153PubMedCrossRefGoogle Scholar
  60. 60.
    Ochs A, Sellinger M, Haag K et al (1992) Transjugular intrahepatic portosystemic shunt for treatment of refractory ascites and hepatorenal syndrome: results of a pilot study. Gastroenterology 102:A863Google Scholar
  61. 61.
    Sturgis TM (1995) Hepatorenal syndrome: resolution after transjugular portosystemic shunt. J Clin Gastroenterol 20(3):141–143CrossRefGoogle Scholar
  62. 62.
    Epstein M (1978) Renal effects of head-out water immersion in man: Implications for an understanding of volume homeostasis. Physiol Rev 58:529–581PubMedGoogle Scholar
  63. 63.
    Yersin B, Burnier M, Magnenat P (1995) Improvement of renal failure with repeated head-out water immersion in patients with hepatorenal syndrome associated with alcoholic hepatitis. Am J Nephrol 15(3):2CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1997

Authors and Affiliations

  • A. F. Hammerle
  • P. Krafft
  • C. Tatschl

There are no affiliations available

Personalised recommendations